← SynDRA
SYN2053699
SynDRA canonical compound SYN2053699 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Mechanism of action | L-type calcium channel blocker |
|---|
Cross-references
Synonyms
- (R)-(+)-Bay-K-8644
- (+)-Bay K8644
- C16H15F3N2O4
- (+)-BAY-K 8644
- (R)-Bay-K-8644
- Tocris-1546
- Bay-K-8644 (R)-(+)-
- BIDD:PXR0106
- SCHEMBL718828
- (R)-BayK8644
- (R)-Bay K8644
- orb1679037
- (+)-BayK8644
- CHEBI:108583
- CHEBI:131349
- HMS3268C15
- EBC-13037
- MFCD00153768
- R(+)-BAY K 8644
- AKOS024456657
- Bay-K-8644(R)-(+)-
- CS-3614
- NCGC00025210-01
- NCGC00161392-01
- DA-48761
- HY-15125
- MS-25574
- BAY-K-8644-(+/-)
- E98637
- EN300-18543981
- BRD-K16695519-001-01-6
- (4R)-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylic acid methyl ester
- 5,5-dimethyltetrahydropyrimidin-2(1H)-one (3-[4-(trifluoromethyl)phenyl]-1-{2-[4-(trifluoromethyl)phenyl]ethenyl}prop-2-en-1-ylidene)hydrazone
- Hydramethylnon
- methyl (4R)-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate
Look up SYN2053699 in the interactive SynDRA portal →